Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The First in the World Human Proof-of-concept Study on Disinfection and Healing Acceleration Capabilities of 222nm Wave Length Narrow Band Ultraviolet Lighting Device

NCT03526068 is registered in ClinicalTrials.gov with National University Hospital, Singapore as lead sponsor.

NCT NCT03526068
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03526068 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The First in the World Human Proof-of-concept Study on Disinfection and Healing Acceleration Capabilities of 222nm Wave Length Narrow Band Ultraviolet Lighting Device
Lead sponsor
National University Hospital, Singapore
Phase
Not applicable
Overall status
Completed
Start date
December 31, 2016
Completion date
January 23, 2019
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ultraviolet rays